In an easy-to-read article in Pharmaceutical Technology, Elizabeth Hill (Head of Transaction Support for Cambridge Consultants Ltd (UK)) discusses the barriers to to entry for generic pharma companies based in emerging economies seeking to grow their businesses in the US and Europe.
"The potential rewards of success for generic pharmaceuticals companies in regulated markets are tempered by the need to overcome regulatory, intellectual property and marketing hurdles to achieve marketing authorization and market access. An understanding of the potential barriers and developing the strategies to overcome these is of value to both companies and potential investors."
